198 related articles for article (PubMed ID: 16239389)
1. Update on rituximab.
Eisenberg R
Ann Rheum Dis; 2005 Nov; 64 Suppl 4(Suppl 4):iv55-7. PubMed ID: 16239389
[No Abstract] [Full Text] [Related]
2. Severe refractory rheumatoid arthritis successfully treated with combination rituximab and anti-tumor necrosis factor-alpha-blocking agents.
Koumakis E; Wipff J; Avouac J; Kahan A; Allanore Y
J Rheumatol; 2009 Sep; 36(9):2125-6. PubMed ID: 19738227
[No Abstract] [Full Text] [Related]
3. Rituximab in rheumatoid arthritis following anti-TNF-associated tuberculosis.
Burr ML; Malaviya AP; Gaston JH; Carmichael AJ; Ostör AJ
Rheumatology (Oxford); 2008 May; 47(5):738-9. PubMed ID: 18375402
[No Abstract] [Full Text] [Related]
4. Remission in early rheumatoid arthritis.
Ma MH; Scott IC; Kingsley GH; Scott DL
J Rheumatol; 2010 Jul; 37(7):1444-53. PubMed ID: 20516031
[TBL] [Abstract][Full Text] [Related]
5. Rituximab (Rituxan) for rheumatoid arthritis.
Med Lett Drugs Ther; 2006 Apr; 48(1233):34-5. PubMed ID: 16625143
[No Abstract] [Full Text] [Related]
6. Comment on: Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis.
Belmonte Serrano MA; Pincus T
Rheumatology (Oxford); 2010 Sep; 49(9):1795-6; author reply 1796-7. PubMed ID: 20484342
[No Abstract] [Full Text] [Related]
7. Development of new-onset psoriasis in a patient receiving infliximab for treatment of rheumatoid arthritis.
Chan CY; Browning JC; Larsen F; Hsu S
Dermatol Online J; 2008 Sep; 14(9):12. PubMed ID: 19061594
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumour necrosis factor alpha therapy modulates ghrelin in patients with severe rheumatoid arthritis.
Gonzalez-Gay MA; Garcia-Unzueta MT; Berja A; Vazquez-Rodriguez TR; Gonzalez-Juanatey C; de Matias JM; Martin J; Dessein PH; Llorca J
Ann Rheum Dis; 2008 Nov; 67(11):1644-6. PubMed ID: 18854515
[No Abstract] [Full Text] [Related]
9. Treatment failure with antagonists of TNF-α: mechanisms and implications for the care of patients.
Desroches M; Louis G; Gleizes A; Krzysiek R; Emilie D
Eur Cytokine Netw; 2010 Dec; 21(4):226-31. PubMed ID: 21084245
[TBL] [Abstract][Full Text] [Related]
10. Should anti-tumor necrosis factor-alpha be the first therapy for rheumatoid vasculitis?
Garcia-Porrua C; Gonzalez-Gay MA; Quevedo V
J Rheumatol; 2006 Feb; 33(2):433; author reply 433-4. PubMed ID: 16465676
[No Abstract] [Full Text] [Related]
11. Infliximab treatment in a patient with rheumatoid arthritis on haemodialysis.
Hammoudeh M
Rheumatology (Oxford); 2006 Mar; 45(3):357-9. PubMed ID: 16368727
[No Abstract] [Full Text] [Related]
12. Long term treatment of rheumatoid arthritis with rituximab.
Caporali R; Caprioli M; Bobbio-Pallavicini F; Bugatti S; Montecucco C
Autoimmun Rev; 2009 Jun; 8(7):591-4. PubMed ID: 19393205
[TBL] [Abstract][Full Text] [Related]
13. Do tumor-necrosis-factor inhibitors prevent first cardiovascular events in patients with rheumatoid arthritis?
Kaplan MJ
Nat Clin Pract Rheumatol; 2005 Dec; 1(2):74-5. PubMed ID: 16932633
[No Abstract] [Full Text] [Related]
14. [Rituximab (Mabthera)--treatment of rheumatoid arthritis patients with inadequate response to TNF inhibitors--when to change therapy?].
Morović-Vergles J
Reumatizam; 2008; 55(2):70-2. PubMed ID: 19024280
[TBL] [Abstract][Full Text] [Related]
15. mAbs in nonlupus autoimmune rheumatic disease.
Whelan BR; Isenberg DA
Curr Opin Hematol; 2009 Jul; 16(4):280-4. PubMed ID: 19444098
[TBL] [Abstract][Full Text] [Related]
16. New drugs for rheumatoid arthritis.
Roberts LJ
N Engl J Med; 2004 Dec; 351(25):2659-61; author reply 2659-61. PubMed ID: 15602032
[No Abstract] [Full Text] [Related]
17. Comparative overview of safety of the biologics in rheumatoid arthritis.
Khraishi M
J Rheumatol Suppl; 2009 Jun; 82():25-32. PubMed ID: 19509327
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-alpha therapy.
Rosner I; Haddad A; Boulman N; Feld J; Avshovich N; Slobodin G; Rozenbaum M
Rheumatology (Oxford); 2007 Sep; 46(9):1508; author reply 1508-9. PubMed ID: 17684027
[No Abstract] [Full Text] [Related]
19. Novel approaches for the treatment of rheumatoid arthritis: lessons from the evaluation of synovial biomarkers in clinical trials.
Gerlag DM; Tak PP
Best Pract Res Clin Rheumatol; 2008 Apr; 22(2):311-23. PubMed ID: 18455687
[TBL] [Abstract][Full Text] [Related]
20. [B cell depletion therapy using anti-CD20 antibodies in rheumatoid arthritis].
Yukawa N; Mimori T
Clin Calcium; 2007 Apr; 17(4):569-76. PubMed ID: 17404487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]